In August 2025, President Duma Boko stood before the nation and announced that Botswana’s medical supply chain had failed. It was not a complex diagnosis. The shelves of government clinics and hospitals were empty — empty of antiretrovirals for people living with HIV, of insulin for diabetic patients, of medication for cancer, for tuberculosis, for hypertension, for asthma, for mental health conditions, for sexual and reproductive health. Elective surgeries had already been postponed. The Health Ministry owed over P1 billion to private health facilities and suppliers. The military was being deployed to distribute emergency medicine convoys from Gaborone to remote districts. The President called the prices charged for medicines “office inflated five to ten times” and described the procurement system as broken.
The proximate explanation was available and accurate: the diamond downturn had drained government revenues, and the United States, under the Trump administration, had cut foreign aid, including funding that had previously covered a third of Botswana’s HIV response and $12 million through The Global Fund for malaria and tuberculosis. These are real causes with real consequences. But they are not the whole explanation, and if they are treated as the whole explanation, Botswana will be precisely as vulnerable the next time one of these variables changes — because the structural conditions that made the crisis possible will not have been addressed.
The Three Legs That Failed Simultaneously
Botswana’s public health system, as it has operated for the past two decades, rested on three load-bearing legs: diamond revenue providing the fiscal base for the Ministry of Health’s operational and procurement budgets; US PEPFAR funding covering a substantial share of the country’s HIV response — by some accounts, the most comprehensive in the region; and The Global Fund providing supplementary financing for HIV, malaria, and tuberculosis control. Each leg was, in isolation, a reasonable source of support. As a system architecture, it was an entirely reasonable arrangement for a middle-income country managing a high HIV burden with limited domestic fiscal capacity.
The problem is that all three legs are external, and all three are independently subject to disruptions that Botswana cannot control. Diamond revenue is hostage to global markets and, increasingly, to the structural shift toward lab-grown diamonds. US foreign aid is hostage to the fiscal priorities and political decisions of an American administration operating from its own domestic pressures. The Global Fund, though more insulated from bilateral political volatility, is still an external institution with its own funding cycles and allocation decisions. When all three wobbled in the same twelve-month period, the system they supported collapsed.
The medicine shortage was not a management failure. It was a design failure — and the design has not yet been fundamentally changed.
What P1 Billion in Debt Reveals
The Health Ministry’s P1 billion debt to private health facilities and suppliers at the point of crisis reveals something specific about how the procurement and payment system had been operating. Long before the acute crisis hit, the ministry had been accumulating arrears — paying suppliers late, running down its credit relationships, and relying on the expectation that revenue would recover before the system became insolvent. The Ministry was given P254 million for medical fees in the 2025/26 financial year, and those funds had already been used to service previous debts before the year’s needs could be met.
This is not the fiscal management of a system temporarily stressed by an unexpected shock. It is the fiscal management of a system that was already under strain and had no buffer to absorb the shock when it came. The buffer — which the Pula Fund was, in theory, designed to provide — had been drawn down. The emergency P250 million approved by the Ministry of Finance for medical procurement in August 2025 was essential and necessary. It was also a reactive measure for a condition that had been building, visibly, for months.
The Mental Health Dimension
Among the medicines that ran out in August 2025 were mental health medications. This detail deserves more attention than it has received. Botswana has fewer than 0.3 psychiatrists per 100,000 people and a single dedicated paediatric psychiatric facility located 80 kilometres from the capital. Research from the University of Botswana’s collaboration with Botswana-Baylor Children’s Clinical Centre of Excellence found suicidal ideation in 29 percent of young people surveyed, depression in nearly 40 percent, and a mental health system with approximately 1.52 psychologists per 100,000 people — a ratio that makes meaningful clinical intervention at population scale essentially impossible.
When mental health medicines ran out in August 2025, patients already managing their conditions through medication lost access to that management with no alternative system available to receive them. In a country with 17.7 mental health practitioners per 100,000 people total — including nurses and community health workers, not only clinical specialists — the removal of pharmaceutical management is not compensated by clinical alternatives, because the clinical alternatives do not exist at the scale required.
The Emergency Is Over. The Architecture That Caused It Is Not
Botswana has, since independence, built one of sub-Saharan Africa’s more functional public health systems, measured by life expectancy, maternal mortality, and HIV management outcomes. That is a real achievement, and it should not be erased by the August 2025 crisis. But the crisis did reveal, with uncomfortable clarity, that the system’s functionality has rested on conditions — diamond revenue, US aid, The Global Fund — rather than on sufficient domestic health financing built to be resilient when external conditions change. The emergency response addressed the immediate shortage. It did not change the architecture. The next time one of those external conditions shifts, and they will, the architecture will be exactly as exposed as it was in August 2025. That is the harder lesson of the medicine shortage — and the one that demands a policy response beyond emergency procurement convoys.
Sources: Al Jazeera; Sputnik Africa; Daily News Botswana; ITIJ; TRT Afrika; PMC/NIH; University of Botswana/Botswana-Baylor research; Ministry of Finance Botswana